Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Citi
Baxter
Teva
Harvard Business School

Generated: May 23, 2019

DrugPatentWatch Database Preview

Infliximab - Biologic Drug Details

« Back to Dashboard

Summary for infliximab
Tradenames:1
Patents:333
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for infliximab
Pharmacology for infliximab

US Patents for infliximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Try a Free Trial Massachusetts Eye and Ear Infirmary (Boston, MA) ➤ Try a Free Trial RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Try a Free Trial UNIVERSITY OF TROMSO (Tromso, NO) ➤ Try a Free Trial RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Try a Free Trial Knopp Biosciences LLC (Pittsburgh, PA) ➤ Try a Free Trial RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Try a Free Trial Coherus Biosciences, Inc. (Redwood City, CA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for infliximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 Austria ➤ Try a Free Trial PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805
2016000049 Germany ➤ Try a Free Trial PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621
2015000061 Germany ➤ Try a Free Trial PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
2017 00061 Denmark ➤ Try a Free Trial PRODUCT NAME: SARILUMAB; REG. NO/DATE: EU/1/17/1196/001-8 20170627
2015 00006 Denmark ➤ Try a Free Trial PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
AstraZeneca
Fuji
Mallinckrodt
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.